LifeTech Scientific Corporation
LFTSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $676,707 | $650,868 | $652,831 | $627,670 |
| % Growth | 4% | -0.3% | 4% | – |
| Cost of Goods Sold | $178,952 | $184,817 | $137,447 | $136,838 |
| Gross Profit | $497,755 | $466,051 | $515,384 | $490,832 |
| % Margin | 73.6% | 71.6% | 78.9% | 78.2% |
| R&D Expenses | $114,459 | $162,989 | $139,926 | $187,314 |
| G&A Expenses | $118,369 | $91,989 | $72,594 | $89,504 |
| SG&A Expenses | $369,274 | $281,625 | $222,577 | $236,323 |
| Sales & Mktg Exp. | $250,905 | $189,636 | $149,983 | $146,153 |
| Other Operating Expenses | -$50,365 | $37,107 | -$49,125 | -$60,878 |
| Operating Expenses | $433,368 | $481,721 | $313,378 | $362,759 |
| Operating Income | $64,387 | -$15,670 | $202,006 | $128,073 |
| % Margin | 9.5% | -2.4% | 30.9% | 20.4% |
| Other Income/Exp. Net | $15,413 | $6,020 | $6,639 | -$208,913 |
| Pre-Tax Income | $79,800 | -$9,650 | $208,645 | -$80,840 |
| Tax Expense | $38,035 | $7,667 | $22,837 | $24,321 |
| Net Income | $55,074 | $16,831 | $205,557 | $43,078 |
| % Margin | 8.1% | 2.6% | 31.5% | 6.9% |
| EPS | 0.013 | 0.004 | 0.046 | 0.01 |
| % Growth | 225.6% | -91.5% | 379.2% | – |
| EPS Diluted | 0.013 | 0.004 | 0.046 | 0.01 |
| Weighted Avg Shares Out | 4,344,061 | 4,379,345 | 4,468,630 | 4,529,758 |
| Weighted Avg Shares Out Dil | 4,350,648 | 4,394,487 | 4,452,162 | 4,391,151 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,122 | $18,569 | $0 | $9,114 |
| Interest Expense | $0 | $1,890 | $0 | -$27 |
| Depreciation & Amortization | $40,072 | $51,209 | $36,787 | $30,955 |
| EBITDA | $70,827 | $80,403 | $208,478 | $121,722 |
| % Margin | 10.5% | 12.4% | 31.9% | 19.4% |